A multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial to evaluate the efficacy and safety of Taltirelin tablets in patients with spinocerebellar ataxia

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 69cf2f95c06559e94acdb42f07e93cd8a24febd7
First added on: Apr 23, 2026